ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      56,726.51
      0.13%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. uniQure NV (QURE)

      7. uniQure NV (QURE) News

      QURE

      uniQure NV (QURE)

      uniQure NV
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:QURE
      DateTimeSourceHeadlineSymbolCompany
      02/04/20207:00AMGlobeNewswire Inc.uniQure Announces Presentations at the Upcoming 13th Annual Congress of the European Association for Haemophilia and Allied D...NASDAQ:QUREuniQure NV
      01/31/20205:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      01/31/20204:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      01/31/20204:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      01/31/20204:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      01/31/20204:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      01/31/20203:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      01/31/20207:00AMGlobeNewswire Inc.uniQure to Participate in Multiple Upcoming Industry Conferences in FebruaryNASDAQ:QUREuniQure NV
      01/29/20206:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      01/29/202011:25AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      01/17/20209:40AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      01/08/20201:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      12/20/20194:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      12/19/20197:00AMGlobeNewswire Inc.uniQure Announces Publication of Preclinical Data for AMT-130 in Huntington’s Disease Supporting Non-Selective HTT-Lowering...NASDAQ:QUREuniQure NV
      12/17/20194:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      12/17/20194:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      12/09/20196:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      12/08/20194:00PMGlobeNewswire Inc.uniQure Announces One-Year Follow-Up Data from the Phase IIb Study of Etranacogene Dezaparvovec and Long-Term Follow-Up Data ...NASDAQ:QUREuniQure NV
      12/02/20197:00AMGlobeNewswire Inc.uniQure to Participate in Multiple Upcoming Industry Conferences in DecemberNASDAQ:QUREuniQure NV
      11/22/201910:13AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      11/19/20198:52AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      11/06/20199:16AMGlobeNewswire Inc.uniQure Announces Clinical Data Presentations at the 61st American Society of Hematology (ASH) Annual MeetingNASDAQ:QUREuniQure NV
      11/05/20195:27PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      11/05/20197:00AMGlobeNewswire Inc.uniQure Announces the Allowance of New Patent Providing Further Protection of the Padua and Padua-Related Variants of Factor ...NASDAQ:QUREuniQure NV
      11/01/20197:00AMGlobeNewswire Inc.uniQure to Participate in Multiple Upcoming Industry Conferences in NovemberNASDAQ:QUREuniQure NV
      10/31/20197:00AMGlobeNewswire Inc.uniQure Announces Publication of Positive Interim Data from Phase IIb Clinical Trial of Etranacogene DezaparvovecNASDAQ:QUREuniQure NV
      10/28/20195:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      10/28/20198:24AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:QUREuniQure NV
      10/28/20197:00AMGlobeNewswire Inc.uniQure Announces Third Quarter 2019 Results and Highlights Recent Company ProgressNASDAQ:QUREuniQure NV
      10/25/20198:39AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
       Showing the most relevant articles for your search:NASDAQ:QURE